Despite subjects’ lack of psychomotor impairment, researchers acknowledged that some participants tested positive for THC at levels classifying them as “under the influence” in several states.
Archives: News Releases
Since 1992, every Thursday and when breaking news warrants, NORML | The NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about cannabis-related news and legislation as well as a research tool for reviewing a chronology of marijuana law reform.
Study participants “demonstrated significantly improved performance on measures of executive function relative to baseline, evidenced by faster response time[s] … as well as higher accuracy.”
Following treatment, two-thirds of the cohort exhibited a greater than 50 percent reduction in seizure frequency.
Investigators suggested that “long-term contact between the metal parts of the CV and the acidic liquid may cause metal dissolution.”
Investigators concluded, “[These findings] provide … support for the idea that legal-market cannabis can serve as substitute for alcohol among some individuals who engage in heavy drinking.”
Researchers reported that cannabis improves outcomes “across multiple metrics,” including better sleep quality, reduced anxiety, and improved health-related quality of life.
Under the new law, patients with chronic pain, Crohn’s disease, traumatic brain injury, and other newly eligible conditions may obtain state-licensed medical cannabis products.
Advocates say that the Governor’s veto will further delay consumers from gaining access to state-licensed marijuana products.
